Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGWP.L Regulatory News (GWP)

  • There is currently no data for GWP

Director Shareholding

2 Mar 2005 14:05

GW Pharmaceuticals PLC02 March 2005 For Immediate Release 2 March 2005 GW Pharmaceuticals plc ('the Company') Share Options The following Directors of the Company have been granted share options on 2March 2005, as detailed below: Director No. of shares over which Total no. of shares over options granted which options held Dr Geoffrey 302,344 1,083,924Guy Justin 239,063 1,491,167Gover David Kirk 217,969 1,773,747 Dr Brian 98,438 678,230Whittle David Mace 45,000 251,620 Hans 45,000 119,120Schram Peter 45,000 179,120Mountford The options to acquire ordinary shares of 0.1p in the Company have been grantedat an exercise price of 128p and are exercisable from 2 March 2008 to 2 March2015 and have been granted as part of the Directors' remuneration review carriedout at the end of 2004. For further information please contact Jonathan Laughton, Company Secretary &Financial Controller, GW Pharmaceuticals plc on +44 (0) 1980 557 000. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Apr 20057:00 amRNSDirector Shareholding
19th Apr 200511:38 amRNSProduct Approval
5th Apr 200510:31 amRNSBlocklisting Interim Review
24th Mar 20059:26 amRNSAdditional Listing
23rd Mar 20057:00 amRNSAppointment
23rd Mar 20057:00 amRNSAGM Resolutions
2nd Mar 20052:05 pmRNSDirector Shareholding
2nd Mar 200510:36 amRNSAdditional Listing
28th Feb 20052:05 pmRNSRe: US Strategy
19th Jan 20057:00 amRNSResearch Update
19th Jan 20057:00 amRNSFinal Results
10th Jan 20052:01 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.